More tools:Markets·Screener·Research·Chat

SelectQuote, Inc. (SLQT) Financial Statements

SelectQuote, Inc.
SIC 6411 · INSURANCE AGENTS, BROKERS & SERVICE
FIGI BBG001SQZ7Z7
XNYS · usd
0.51▼ 0.03 (-5.64%)
As of 2026-09-09
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close0.54
Day's Range0.51 – 0.55
52-Week Range0.48 – 2.22
Volume850.8K
Avg Volume1.1M
Share Statistics
Shares Outstanding
Employees4,269
ExchangeXNYS
Listed2020-05-21
Share count as of July 31, 2026
Loading Income Statement…
Key questions about SelectQuote, Inc. (SLQT)
What is SelectQuote, Inc.'s Market Cap?
SelectQuote, Inc.'s Market Cap is $89.2M, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s Enterprise Value?
SelectQuote, Inc.'s Enterprise Value is $743.2M, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s Price / Sales?
SelectQuote, Inc.'s Price / Sales is 0.1×, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s EV / Revenue?
SelectQuote, Inc.'s EV / Revenue is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s EV / EBITDA?
SelectQuote, Inc.'s EV / EBITDA is 8.2×, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s Revenue (TTM)?
SelectQuote, Inc.'s Revenue (TTM) is $1.6B, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s Net Income (TTM)?
SelectQuote, Inc.'s Net Income (TTM) is -$11.6M, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s EBITDA?
SelectQuote, Inc.'s EBITDA is $91.4M, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s Diluted EPS (TTM)?
SelectQuote, Inc.'s Diluted EPS (TTM) is -0.07, based on as-reported figures from SEC (XBRL) filings.
What is SelectQuote, Inc.'s EBITDA Margin?
SelectQuote, Inc.'s EBITDA Margin is 5.6%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
REVENUE:
Total revenue
YoY growth-6.8%+5.6%+11.6%+12.5%
OPERATING COSTS AND EXPENSES:
Cost of commissions and other services revenue
Cost of goods sold—pharmacy revenue
Marketing and advertising
Selling, general, and administrative
Technical development
Total operating costs and expenses
% of revenue98.9%91.7%86.0%112.4%
INCOME FROM OPERATIONS
% of revenue1.1%8.3%14.0%-12.4%
INTEREST EXPENSE, NET
CHANGE IN FAIR VALUE OF WARRANTS
LOSS ON EXTINGUISHMENT OF DEBT——
OTHER EXPENSE, NET
INCOME (LOSS) BEFORE INCOME TAX EXPENSE
INCOME TAX EXPENSE
NET INCOME (LOSS)
% of revenue-5.2%9.3%12.9%-9.3%
Senior Non-Convertible Preferred Stock accumulated dividends and accretion
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS
NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS PER SHARE:
Basic (in dollars per share)—
Diluted (in dollars per share)—